LIP
Lighthouse Investment Partners Portfolio holdings
AUM
$2.3B
1-Year Return
18.81%
This Quarter Return
+2.77%
1 Year Return
+18.81%
3 Year Return
+54.09%
5 Year Return
–
10 Year Return
–
AUM
$1.15B
AUM Growth
+$608M
(+112%)
Cap. Flow
+$583M
Cap. Flow
% of AUM
50.63%
Top 10 Holdings %
Top 10 Hldgs %
18.54%
Holding
385
New
148
Increased
49
Reduced
52
Closed
127
Top Buys
| 1 |
Keurig Dr Pepper
KDP
|
$26.4M |
| 2 |
Alliant Energy
LNT
|
$19.7M |
| 3 |
Prologis
PLD
|
$19.7M |
| 4 |
CenterPoint Energy
CNP
|
$18.5M |
| 5 |
Public Service Enterprise Group
PEG
|
$18.4M |
Top Sells
| 1 |
Colgate-Palmolive
CL
|
$16.1M |
| 2 |
Philip Morris
PM
|
$14.7M |
| 3 |
BP
BP
|
$9.94M |
| 4 |
Estee Lauder
EL
|
$9.92M |
| 5 |
Lamb Weston
LW
|
$9.83M |
Sector Composition
| 1 | Consumer Staples | 23.18% |
| 2 | Real Estate | 23.02% |
| 3 | Utilities | 17.65% |
| 4 | Industrials | 11.16% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
226
DELISTED
Cymabay Therapeutics
CBAY
| $88K | 0.01% |
10,092
-30,001
| -75% | -$262K |
|
227
Lineage Cell Therapeutics
LCTX
$279M
| $84.9K | 0.01% |
+56,626
| New | +$84.9K |
|
|
LCAHW
228
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
| $82.3K | 0.01% |
+500,000
| New | +$82.3K |
|
|
MRNS
229
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $82K | 0.01% |
11,888
-5,040
| -30% | -$34.8K |
|
|
OSG
230
DELISTED
Overseas Shipholding Group Inc.
OSG
| $77.7K | 0.01% |
19,914
-11,004
| -36% | -$42.9K |
|
231
Accuray
ARAY
$170M
| $77K | 0.01% |
25,914
-13,416
| -34% | -$39.8K |
|
|
LUNA
232
DELISTED
Luna Innovations Incorporated
LUNA
| $73.6K | ﹤0.01% |
+10,240
| New | +$73.6K |
|
233
Evolution Petroleum
EPM
$174M
| $73.6K | ﹤0.01% |
11,657
-2,557
| -18% | -$16.1K |
|
|
QIPT
234
Quipt Home Medical
QIPT
$113M
| $73.1K | ﹤0.01% |
+10,431
| New | +$73.1K |
|
235
Assertio
ASRT
$76.8M
| $69.6K | ﹤0.01% |
+10,921
| New | +$69.6K |
|
236
Compass Therapeutics
CMPX
$590M
| $67.8K | ﹤0.01% |
20,723
+6,061
| +41% | +$19.8K |
|
237
Pangaea Logistics
PANL
$349M
| $62.2K | ﹤0.01% |
10,599
-5,489
| -34% | -$32.2K |
|
238
Zevra Therapeutics
ZVRA
$502M
| $58.6K | ﹤0.01% |
10,658
-4,838
| -31% | -$26.6K |
|
|
GRTS
239
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $53.2K | ﹤0.01% |
19,149
-12,269
| -39% | -$34.1K |
|
240
CorMedix
CRMD
$926M
| $50.8K | ﹤0.01% |
12,264
-4,113
| -25% | -$17K |
|
241
Acacia Research
ACTG
$318M
| $45.7K | ﹤0.01% |
11,849
-8,701
| -42% | -$33.6K |
|
242
Annexon
ANNX
$238M
| $43.3K | ﹤0.01% |
11,250
-5,310
| -32% | -$20.4K |
|
243
Citius Pharmaceuticals
CTXR
$20.9M
| $42.3K | ﹤0.01% |
+1,445
| New | +$42.3K |
|
|
CAMP
244
DELISTED
CalAmp Corp.
CAMP
| $39.7K | ﹤0.01% |
+481
| New | +$39.7K |
|
|
PHLT
245
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $34.9K | ﹤0.01% |
+10,264
| New | +$34.9K |
|
246
Puma Biotechnology
PBYI
$253M
| $34.8K | ﹤0.01% |
+11,276
| New | +$34.8K |
|
|
GTHX
247
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $32K | ﹤0.01% |
11,926
-10,994
| -48% | -$29.5K |
|
248
Standard BioTools
LAB
$497M
| $28.5K | ﹤0.01% |
+14,609
| New | +$28.5K |
|
249
Stereotaxis
STXS
$264M
| $26.8K | ﹤0.01% |
+13,137
| New | +$26.8K |
|
|
KG
250
Kestrel Group, Ltd.
KG
$200M
| $26.4K | ﹤0.01% |
+631
| New | +$26.4K |
|